This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

A recent study in the journal PNAS from the lab of Julie Overbaugh reveals a previously unknown antiviral function of a gene ...

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today congratulates its scientific co-founder, Professor Chad A. Mirkin, on being awarded the ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

Bispecific antibodies bring multiple tumor-cell-killing mechanisms into play simultaneously. When a T cell is activated and ...

A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...

Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.

A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...

Almost two thirds of patients with T-cell acute lymphoblastic leukaemia involved in a clinical trial of the treatment are now ...

This list exemplifies the hard work in science over this past year, not simply in the lab but where it matters.

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street ...